Research – Health & life sciences

Redesigning the pharmaceutical R&D landscape for the post-COVID-19 economy

Assessing the distribution of research efforts among small companies, large companies and universities can provide important – and urgent – insights into the design of policies to encourage and support pharmaceutical innovation to combat COVID-19 and other diseases.

Read more